索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]秦一丁,侯晓晴,公晓雨,等.线粒体结构和功能障碍在扩张型心肌病中的作用[J].国际心血管病杂志,2025,01:17-20.
点击复制

线粒体结构和功能障碍在扩张型心肌病中的作用(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2025年01期
页码:
17-20
栏目:
综述
出版日期:
2025-01-25

文章信息/Info

Title:
-
作者:
秦一丁; 侯晓晴; 公晓雨; 夏琳惠; 鲁雪仪; 夏勇; 栗方芝
272067 济宁医学院临床医学院（秦一丁，鲁雪仪，侯晓晴，公晓雨，夏琳惠），医药工程学院（夏勇）；261500 潍坊，高密市人民医院呼吸与危重症医学科（栗方芝）
Author(s):
-
关键词:
扩张型心肌病; 线粒体; 氧化磷酸化; 线粒体DNA
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2025.01.005
文献标识码:
-
摘要:
扩张型心肌病（DCM）是引起心力衰竭、心律失常和猝死的常见疾病，发病机制未明，其中线粒体结构和功能异常与DCM密切相关。该文介绍线粒体氧化磷酸化和线粒体DNA异常参与调控DCM的机制，并探讨线粒体异常相关DCM的治疗策略。
Abstract:
-

参考文献/References

[1] Baldasseroni S, Opasich C , Gorini M, et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5 517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure[J]. Am Heart J, 2002, 143(3):398-405.
[2] Wang XQ, Zhang X, Cao K, et al. Cardiac disruption of SDHAF4-mediated mitochondrial complex Ⅱ assembly promotes dilated cardiomyopathy[J]. Nat Commun, 2022, 13(1):3947.
[3] Stoldt S, Wenzel D, Kehrein K, et al. Spatial orchestration of mitochondrial translation and OXPHOS complex assembly[J]. Nat Cell Biol, 2018, 20(5):528-534.
[4] Mason FE, Pronto JRD, Alhussini K, et al. Cellular and mitochondrial mechanisms of atrial fibrillation[J]. Basic Res Cardiol, 2020, 115(6):72.
[5] Rabinovich-Nikitin I, Rasouli M, Reitz CJ, et al. Mitochondrial autophagy and cell survival is regulated by the circadian Clock gene in cardiac myocytes during ischemic stress[J]. Autophagy, 2021, 17(11):3794-3812.
[6] Arbustini E, Diegoli M, Fasani R, et al. Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy[J]. Am J Pathol, 1998, 153(5):1501-1510.
[7] Wu W, Ziemann M, Huynh K, et al. Activation of Hippo signaling pathway mediates mitochondria dysfunction and dilated cardiomyopathy in mice[J]. Theranostics, 2021, 11(18):8993-9008.
[8] Kharechkina ES, Nikiforova AB, Belosludtsev KN, et al. Pioglitazone is a mild carrier-dependent uncoupler of oxidative phosphorylation and a modulator of mitochondrial permeability transition[J]. Pharmaceuticals (Basel), 2021, 14(10):1045.
[9] Shankar TS, Ramadurai DKA, Steinhorst K, et al. Cardiac-specific deletion of voltage dependent anion channel 2 leads to dilated cardiomyopathy by altering calcium homeostasis[J]. Nat Commun, 2021, 12(1):4583.
[10] Li EM, Li XY, Huang J, et al. BMAL1 regulates mitochondrial fission and mitophagy through mitochondrial protein BNIP3 and is critical in the development of dilated cardiomyopathy[J]. Protein Cell, 2020, 11(9):661-679.
[11] Enomoto H, Mittal N, Inomata T, et al. Dilated cardiomyopathy-linked heat shock protein family D member 1 mutations cause up-regulation of reactive oxygen species and autophagy through mitochondrial dysfunction[J]. Cardiovasc Res, 2021, 117(4):1118-1131.
[12] Shadel GS, Horvath TL. Mitochondrial ROS signaling in organismal homeostasis[J]. Cell, 2015, 163(3):560-569.
[13] Pang S, Dong W, Liu N, et al. Diallyl sulfide protects against dilated cardiomyopathy via inhibition of oxidative stress and apoptosis in mice[J]. Mol Med Rep, 2021, 24(6):852.
[14] 李文, 马沛然, 汪翼, 等. 扩张型心肌病患儿线粒体DNA点突变研究[J]. 实用儿科临床杂志, 2001, 16(1):1-2.
[15] Bi YG, Xu HX, Wang X, et al. FUNDC1 protects against doxorubicin-induced cardiomyocyte PANoptosis through stabilizing mtDNA via interaction with TUFM[J]. Cell Death Dis, 2022, 13(12):1020.
[16] Samir P, Malireddi RKS, Kanneganti TD. The PANoptosome: adeadly protein complex driving pyroptosis, apoptosis, and necroptosis (PANoptosis)[J]. Front Cell Infect Microbiol, 2020, 10:238.
[17] Qi YJ, Wu ZH, Bai YB, et al. Screening for mitochondrial tRNA mutations in 318 patients with dilated cardiomyopathy[J]. Hum Hered, 2022, 87(1):1-11.
[18] Tseng WW, Wei AC. Kinetic mathematical modeling of oxidative phosphorylation in cardiomyocyte mitochondria[J]. Cells, 2022, 11(24):4020.
[19] Berry EA, Guergova-Kuras M, Huang LS, et al. Structure and function of cytochrome bc complexes[J]. Annu Rev Biochem, 2000, 69(1):1005-1075.
[20] Yeh JN, Yue Y, Chu YC, et al. Entresto protected the cardiomyocytes and preserved heart function in cardiorenal syndrome rat fed with high-protein diet through regulating the oxidative stress and Mfn2-mediated mitochondrial functional integrity[J]. Biomed Pharmacother, 2021, 144:112244.
[21] Zhao KS, Zhao GM, Wu DL, et al. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury[J]. J Biol Chem, 2004, 279(33):34682-34690.
[22] Dai DF, Chen T, Szeto H, et al. Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy[J]. J Am Coll Cardiol, 2011, 58(1):73-82.
[23] Lee FY, Shao PL, Wallace CG, et al. Combined therapy with SS31 and mitochondria mitigates myocardial ischemia-reperfusion injury in rats[J]. Int J Mol Sci, 2018, 19(9):2782.
[24] Yeh JN, Sung PH, Chiang JY, et al. Early treatment with combination of SS31 and entresto effectively preserved the heart function in doxorubicin-induced dilated cardiomyopathic rat[J]. Biomed Pharmacother, 2021, 141:111886.
[25] Lu D, Ma YW, Zhang W, et al. Knockdown of cytochrome P450 2E1 inhibits oxidative stress and apoptosis in the cTnT(R141W) dilated cardiomyopathy transgenic mice[J]. Hypertension, 2012, 60(1):81-89.
[26] Guan FF, Yang XL, Li J, et al. New molecular mechanism underlying Myc-mediated cytochrome P450 2E1 upregulation in apoptosis and energy metabolism in the myocardium[J]. J Am Heart Assoc, 2019, 8(1):e009871.
[27] Kuzgun G, Ba?aran R, Ar?o?lu ?nan E, et al. Effects of insulin treatment on hepatic CYP1A1 and CYP2E1 activities and lipid peroxidation levels in streptozotocin-induced diabetic rats[J]. J Diabetes Metab Disord, 2020, 19(2):1157-1164.
[28] Santra S, Bishnu D, Dhali GK, et al. Expression of type Ⅰcollagen in response to Isoniazid exposure is indirect and is facilitated by collateral induction of cytochrome P450 2E1: an in-vitro study[J]. PLoS One, 2020,15(7):e0236992.
[29] Tobeiha M, Jafari A, Fadaei S, et al. Evidence for the benefits of melatonin in cardiovascular disease[J]. Front Cardiovasc Med, 2022, 9:888319.
[30] Misaka T, Yoshihisa A, Yokokawa T, et al. Plasma levels of melatonin in dilated cardiomyopathy[J]. J Pineal Res, 2019, 66(4):e12564.
[31] Odinokova I, Baburina Y, Kruglov A, et al. Effect of melatonin on rat heart mitochondria in acute heart failure in aged rats[J]. Int J Mol Sci, 2018, 19(6):1555.
[32] Chua S, Lee FY, Chiang HJ,et al. The cardioprotective effect of melatonin and exendin-4 treatment in a rat model of cardiorenal syndrome[J]. J Pineal Res, 2016, 61(4):438-456.
[33] Zhang W, Wang X, Tang YH, et al. Melatonin alleviates doxorubicin-induced cardiotoxicity via inhibiting oxidative stress, pyroptosis and apoptosis by activating Sirt1/Nrf2 pathway[J]. Biomed Pharmacother, 2023, 162:114591.
[34] Zhang Y, Wang Y, Xu JN, et al. Melatonin attenuates myocardial ischemia-reperfusion injury via improving mitochondrial fusion/mitophagy and activating the AMPK-OPA1 signaling pathways[J]. J Pineal Res, 2019, 66(2):e12542.
[35] Zhang AL, Liu YY, Pan J, et al. Delivery of mitochondria confers cardioprotection through mitochondria replenishment and metabolic compliance[J]. Mol Ther, 2023, 31(5):1468-1479.
[36] Bartolucci J, Verdugo FJ, González PL, et al. Safety and efficacy of the intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure: aphase 1/2 randomized controlled trial (RIMECARD trial [Randomized clinical trial of intravenous infusion umbilical cord mesenchymal stem cells on cardiopathy])[J]. Circ Res, 2017, 121(10):1192-1204.
[37] Li JC, Xuan H, Kuang X, et al. Cas13b-mediated RNA targeted therapy alleviates genetic dilated cardiomyopathy in mice[J]. Cell Biosci, 2024, 14(1):4.

备注/Memo

备注/Memo:
基金项目：山东省泰山学者青年专家项目（tsqn201909147）
通信作者：栗方芝， E-mail：lifangzhihuxi@126.com
更新日期/Last Update: 2025-02-10